Cemone Khan
Optometrist · la Palma, CANPI 1275076721
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,039 and has fallen 88.4% since, to $121 in 2024. Among optometrist clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $36.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$716
- Bausch & Lomb, A Division Of Bausch Health US, LLC$583
- Dompe US, Inc.$413
- Sun Pharmaceutical Industries Inc.$381
- Aerie Pharmaceuticals, Inc.$291
- Shire North American Group Inc$193
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,73899%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $716 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 19 | $583 |
| Dompe US, Inc. | 7 | $413 |
| Sun Pharmaceutical Industries Inc. | 12 | $381 |
| Aerie Pharmaceuticals, Inc. | 10 | $291 |
| Shire North American Group Inc | 4 | $193 |
| Sight Sciences, Inc. | 7 | $167 |
| Glaukos Corporation | 2 | $153 |
| Novartis | 7 | $142 |
| Rxsight Inc | 2 | $140 |
| Amgen | 1 | $123 |
| Apellis Pharmaceuticals, Inc. | 1 | $121 |
| Ocular Therapeutix, Inc. | 6 | $110 |
| Oyster Point Pharma, Inc. | 4 | $96 |
| Bausch & Lomb Americas Inc. | 3 | $72 |
| Alcon | 2 | $38 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxervate$249
- RESTASIS$236
- RESTASIS MULTIDOSE$127
- iStent inject Trabecular Micro-Bypass Stent System$126
- CEQUA$125
- Rocklatan$125
- Rhopressa$125
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$124
- TEPEZZA$123
- VUITY$121
- Syfovre$121
- VYZULTA$119
- XIIDRA$114
How this compares
$3,757 in reported general payments places this provider in the 90th percentile of 6,778 optometrist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 42 | $311 |
Paid to pharmacies, not to this prescriber.
Other optometrist in la Palma
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
- Katie ChuRosemead$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.